ArticlePharmaceutical research2026
The Impact of Particle Properties on High Concentration Suspension Performance and Stability of Spray-Dried Monoclonal Antibodies.
Article in Pharmaceutical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSubcutaneous (subQ) administration of biologic drug products is increasingly preferred to enable patient self-administration and reduce healthcare burden. However, the small dosing volume for subQ delivery necessitates high-concentration formulations, which often suffer from elevated viscosity and physical instability, creating challenges in manufacturing, injectability, and storage. Spray drying has emerged as a versatile particle engineering technique to produce solid biologic powders that can be redispersed into suspensions. While suspensions of spray-dried particles have shown promise in reducing viscosity compared to liquid solutions, the influence of biologic particle properties on suspension performance remains poorly understood. This study aimed to elucidate how particle size and surface characteristics affect viscosity and stability of high-concentration monoclonal antibody (mAb) suspensions.
methodsSpray-dried mAb particles were prepared with varied sizes and leucine addition. Suspensions were evaluated for viscosity, injectability through 27G needles, sedimentation, physical, chemical and structural stability during storage at 5°C and 25°C for 3 months and at 40°C for 1 month.
resultsLarger particle size, less surface dimpling and leucine addition significantly reduced viscosity without compromising physical and chemical stability; no sedimentation was observed. All suspensions were injectable via 27G needles. No notable aggregation or fragmentation occurred under tested conditions.
conclusionParticle size and surface properties modulate suspension viscosity but do not impact stability. Particle engineering through spray drying represents an effective approach to enable high-concentration biologic suspensions for subQ delivery.
Indexed as
Identifiers
41981217What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.